- Home
- KE vs VSTM Comparison
KE vs VSTM Comparison
Compare KE & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KE
- VSTM
- Stock Information
- Founded
- KE 1961
- VSTM 2010
- Country
- KE United States
- VSTM United States
- Employees
- KE N/A
- VSTM N/A
- Industry
- KE Electrical Products
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- KE Technology
- VSTM Health Care
- Exchange
- KE Nasdaq
- VSTM Nasdaq
- Market Cap
- KE 451.8M
- VSTM 425.9M
- IPO Year
- KE N/A
- VSTM 2012
- Fundamental
- Price
- KE $19.67
- VSTM $4.69
- Analyst Decision
- KE Buy
- VSTM Strong Buy
- Analyst Count
- KE 5
- VSTM 9
- Target Price
- KE $22.20
- VSTM $12.63
- AVG Volume (30 Days)
- KE 133.3K
- VSTM 2.5M
- Earning Date
- KE 08-12-2025
- VSTM 08-07-2025
- Dividend Yield
- KE N/A
- VSTM N/A
- EPS Growth
- KE N/A
- VSTM N/A
- EPS
- KE 0.71
- VSTM N/A
- Revenue
- KE $1,536,413,000.00
- VSTM $10,000,000.00
- Revenue This Year
- KE N/A
- VSTM $129.06
- Revenue Next Year
- KE N/A
- VSTM $306.32
- P/E Ratio
- KE $27.63
- VSTM N/A
- Revenue Growth
- KE N/A
- VSTM N/A
- 52 Week Low
- KE $12.41
- VSTM $2.10
- 52 Week High
- KE $24.45
- VSTM $9.10
- Technical
- Relative Strength Index (RSI)
- KE 68.85
- VSTM 39.03
- Support Level
- KE $19.85
- VSTM $4.60
- Resistance Level
- KE $20.50
- VSTM $4.90
- Average True Range (ATR)
- KE 0.44
- VSTM 0.32
- MACD
- KE 0.02
- VSTM 0.10
- Stochastic Oscillator
- KE 87.34
- VSTM 64.29
About KE Kimball Electronics Inc.
Kimball Electronics Inc is a contract electronic manufacturing services company. The company is engaged in producing durable electronics for the automotive, medical, industrial, and public safety end markets. The company's engineering, manufacturing, and supply chain services utilize common production and support capabilities. It is also engaged in producing safety-critical electronic assemblies for its automotive customers. Geographically, it has business units located in the United States, China, Mexico, Poland, Romania, and Thailand. The company derives maximum revenue from Mexico.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.